ACE Research

📢Global Health EDCTP3 Finance and Project Management Training We are proud to announce that our team members, Victorine Owira and Sharon Achieng Odhiambo, successfully completed the #EDCTP3 Project and Management Training held in Nairobi this September! Our team's participation and active engagement not only earned them certificates of attendance but also contributed to the success of this vital training program. We believe continuous learning and global collaboration are key to proper research grant management and advancing clinical trials especially in the global south. A big thank you to Global Health EDCTP3, the organizers and participants for this enriching experience! #ClinicalTrials #AfricaCDC #Biotech #EDCTP3 #CRO #GlobalHealth #ClinicalDevelopment #ClinicalResearch #Mpox #ProfessionalDevelopment #Marburg

🚨 WHO: First Mpox Vaccine Prequalification 🚨 The World Health Organization has added Bavarian Nordic’s Imvanex to its list of prequalified #vaccines, a significant step in the fight against #mpox. 🌍 WHY IT MATTERS This designation will allow for faster and broader access to the vaccine, which is crucial during the current global mpox outbreak. 🦠 BACKSTORY Since 2022, the mpox outbreak has affected over 103,000 individuals across more than 120 countries. Imvanex, originally developed as a smallpox vaccine, is now authorized for adults in a two-dose regimen but can be administered as a single dose in outbreak scenarios with limited supply. Although not licensed for those under 18, it can be used in younger populations if the benefits outweigh the risks during outbreaks. BIG PICTURE This development is crucial for Africa and for global preparedness for potential future outbreaks. It emphasizes the urgent need to scale up vaccine procurement, donations, and distribution alongside other public health measures to prevent infections and transmission. The #WHO’s prequalification of Imvanex is a significant step in the fight against mpox, enhancing global health security and equity. BY NUMBERS • Over 103,000 mpox cases globally since 2022 • IMVANEX effectiveness: 76% (single dose), 82% (two doses) • Affected regions: More than 120 countries 📊 READ MORE 🔗 https://lnkd.in/eNjybDAz What are your thoughts on this advancement? 💭 Share in the comment section below 👇 #Pharmaceuticals #Biotechnology #VaccineDevelopment #GlobalHealth #Mpox #ClinicalTrials #ClinicalResearch #GlobalHealth #AfricaCDC #WHO

📣We’re thrilled to be part of the incredible PregInPoxVac consortium! 🌍 Together with the University of Kinshasa, University of Antwerp and Penta Foundation - Child Health Research, we’re at the forefront in the fight against #mpox. 🔬 Our team is proud to co-lead a Phase 3 #vaccine trial and overall scientific management, focusing on maternal and infant health, to assess the safety and immunogenicity of a promising vaccine candidate in Democratic Republic of Congo (#DRC). We are grateful to Global Health EDCTP3 for the support. #GlobalHealth #CRO #DRC #Innovation #Healthcare #clinicalresearch #clinicaltrial

New project 🎉! We're proud to be a partner in #PregInPoxVac with Universiteit Antwerpen, Department of Tropical Medicine UNIKIN/DRC at Université de Kinshasa (UNIKIN) and ACE Research. Penta will lead a qualitative study on #mpox vaccine acceptability and attitudes to participation in pregnancy vaccine trials among pregnant people, their families, healthcare professionals and the wider community in the Democratic Republic of the Congo. Our research will guide the implementation of the MVA-BN mpox vaccine trial for pregnant people and children, and help raise awareness of the benefits of vaccinating during pregnancy! 👏

🎉ACE Research is proud to be a Silver Sponsor at the Clinical Research Society of Kenya (CRSK) Gala! We are thrilled to support this prestigious event, celebrating medical research innovation, collaboration, and the relentless pursuit of excellence in clinical research. This partnership underscores our dedication to the Kenyan research community and our shared vision for a healthier future. We thank industry leaders, researchers, and collaborators who are as passionate about making a difference as we are. #ClinicalResearch #Kenya #Healthcare #ACEresearch #CRSKGala2024 #Sponsorship

We are thrilled to announce our new partnership with CEPI (Coalition for Epidemic Preparedness Innovations) to advance #mpox vaccination in Africa.

Our team is grateful to the VIBRI Consortium and partners Rinda Ubuzima, University of Kinshasa, and Victoria Biomedical Research Institute (VIBRI) for recognizing our efforts towards achieving significant milestones during the second Investigator Meeting held in Rwanda on April 19th and 20th, 2024. We are proud of the successes in this ongoing Phase 2B research study evaluating the safety and immunogenicity of homologous and heterologous COVID-19 vaccine booster regimens for adolescents and adults living with HIV. The valuable insights gained will assist COVAX, the global initiative for equitable vaccine access, with vaccine providers and governments worldwide, in optimizing vaccination schedules. This optimization is vital to increase COVID-19 protection for people living with HIV. We also thank CEPI (Coalition for Epidemic Preparedness Innovations) for supporting the Consortium's research program. #clinicalresearch #covid19 #clinicaltrials #globalhealth

Emerging diseases lessons learned from our colleagues Drs David Hoover and Jerry Brown. Proud to have been a strong partner for the Ebola convalescent trial therapies in West Africa. #cro #cra #clinicaltrials #clinicalresearch #vaccines

D2 The World Vaccine Congress, Washington DC. The synergy between industry, academia, and government has historically paved the way for the development of safe and effective vaccines to combat public health emergencies. At ACE Research, we're at the forefront of maintaining momentum in conducting vaccine clinical trials across Africa. Our strategy includes: 1. Streamlining regulatory procedures for efficiency. 2. Leveraging R&D capabilities and infrastructure to ensure preparedness. 3. Fostering long-lasting partnerships with the MOH, clinical sites, academic institutions, and local communities. Connect with our team at #WVC2024 Booth #362 #clinicaltrials #clinicalresearch #globalhealth #publichealth

After two years of virtual calls... I finally got to meet Victorine Owira in person. #WVC2024 #WorldVaccineCongress #CRScube #ACEResearch